PM
NAVB
Platinum Management’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $14.7M | Buy |
15,575,946
+12,125,977
| +351% | +$11.5M | 89.51% | 1 |
|
|
2015
Q4 | $4.59M | Sell |
3,449,969
-9,256,355
| -73% | -$12.3M | 67.86% | 1 |
|
|
2015
Q3 | $29M | Buy |
12,706,324
+513,997
| +4% | +$1.17M | 93.09% | 1 |
|
|
2015
Q2 | $19.6M | Buy |
12,192,327
+737,496
| +6% | +$1.19M | 86.22% | 1 |
|
|
2015
Q1 | $18.2M | Sell |
11,454,831
-3,148,772
| -22% | -$5.01M | 94.21% | 1 |
|
|
2014
Q4 | $27.6M | Sell |
14,603,603
-442,828
| -3% | -$837K | 59.19% | 1 |
|
|
2014
Q3 | $19.9M | Buy |
15,046,431
+130,800
| +0.9% | +$173K | 4.55% | 1 |
|
|
2014
Q2 | $22.1M | Buy |
14,915,631
+842,200
| +6% | +$1.25M | 3.13% | 2 |
|
|
2014
Q1 | $26M | Buy |
14,073,431
+3,698,102
| +36% | +$6.84M | 12.3% | 1 |
|
|
2013
Q4 | $13.5M | Buy |
10,375,329
+1,014,053
| +11% | +$1.32M | 19.76% | 1 |
|
|
2013
Q3 | $24.8M | Buy |
9,361,276
+166,759
| +2% | +$442K | 13.33% | 1 |
|
|
2013
Q2 | $24.5M | Buy |
+9,194,517
| New | +$24.5M | 8.64% | 1 |
|